Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2006
09/05/2006US7101562 Conjugate vaccines for the prevention of dental caries
09/05/2006US7101559 Immunomodulatory protein and useful embodiments thereof
09/05/2006US7101558 bvg-positive Bordetella bronchiseptica strain; grows at a higher rate, more reliably in a less expensive medium; purity
09/05/2006US7101556 Preparation and usage of plasmodium fusion antigen
09/05/2006US7101555 Microorganismal polypeptides for use in diagnosis and treatment of respiratory system disorders; genetic vaccines
09/05/2006US7101554 Picornaviruses, vaccines and diagnostic kits
09/05/2006US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response
09/05/2006US7101548 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology
09/05/2006US7101546 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells
09/05/2006US7101542 Cell-mediated targeting of toxins to pathogenic cells
09/05/2006US7101541 Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution
09/05/2006US7101540 Targeted retrograde gene delivery to motor neurons
09/05/2006US7101077 Device for fast vibration of tubes containing samples
09/05/2006CA2255599C Light-controlled electrokinetic assembly of particles near surfaces
09/05/2006CA2143642C Immunoreactive peptides from epstein-barr virus
09/05/2006CA1341511C Method of contolling plant pests
09/02/2006CA2496690A1 A novel c. elegans p21-activated kinase (pak) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of pak activity in the nematode, caenorhabditis elegans
08/2006
08/31/2006WO2006091915A2 Immunostimulatory oligonucleotides
08/31/2006WO2006091871A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
08/31/2006WO2006091852A2 Novel genetic approaches to reduce or inhibit tumorgenicity of human embryonic stem cells and derivatives following transplantation
08/31/2006WO2006091841A2 Compositions and their uses directed to il-4r alpha
08/31/2006WO2006091824A2 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
08/31/2006WO2006091803A2 Transcriptional regulation of cytokines by litaf and stat6(b)
08/31/2006WO2006091717A1 Sperm cell separation methods and compositions
08/31/2006WO2006091677A1 Yeast strains expressing ribosome-inactivating protein domain and method of using same
08/31/2006WO2006091483A1 Phage-derived vectors and methods for protein expression
08/31/2006WO2006091470A2 Improved halohydrin dehalogenases and related polynucleotides
08/31/2006WO2006091194A1 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
08/31/2006WO2006091112A1 Compositions for the delivery of rna interference molecules and methods for their use
08/31/2006WO2006091045A1 Gene delivery system containing decorin gene and pharmaceutical composition for treating cancer containing the system
08/31/2006WO2006090932A1 Surrogate marker for sulfonamide compound
08/31/2006WO2006090918A1 Diabetes model animal
08/31/2006WO2006090912A1 Novel plasmid autonomously replicable in enterobacteriaceae family
08/31/2006WO2006090906A1 NOVEL METHOD FOR OVERCOMING RNAi-RESISTANT STRAIN OF VIRUS
08/31/2006WO2006090900A1 Preventives/remedies for cancer
08/31/2006WO2006090868A1 Gene structure predicting method and gene structure predicting program
08/31/2006WO2006090848A1 Method for detection of nucleotide polymorphism in gene used for diagnosing effect of methotrexate therapy in rheumatoid arthritis patient
08/31/2006WO2006090814A1 Process for producing optically active secondary alcohol
08/31/2006WO2006090803A1 Transcriptome data processing method and apparatus therefor
08/31/2006WO2006090750A1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
08/31/2006WO2006090724A1 Transgenic mouse or transgenic rat having mutant trpv3 gene introduced therein
08/31/2006WO2006090689A1 Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of siv-pedf vector
08/31/2006WO2006090679A1 METHOD FOR DETECTION OF DNA DAMAGE USING Frag1 GENE OR GENE PRODUCT THEREOF AS MARKER
08/31/2006WO2006090381A1 Molecular optoelectronic device and method of fabricating the same
08/31/2006WO2006090241A2 Method of creating or selecting recombinant genes
08/31/2006WO2006090090A2 Hiv epitopes and pharmaceutical composition containing same
08/31/2006WO2006089980A1 Nucleic acids and allergens of olive tree pollen of defined olive tree varieties and applications thereof
08/31/2006WO2006089951A1 Modified acyl transferases for the production of different lactam antibiotics
08/31/2006WO2006089950A2 Expression cassettes for seed-preferential expression in plants
08/31/2006WO2006089912A1 Bacteriophage-based contrast agents, the use thereof and a method for the production thereof
08/31/2006WO2006089911A2 Expression cassettes for seed-preferential expression in plants
08/31/2006WO2006089898A1 Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof
08/31/2006WO2006089808A1 Methods and means for the production of hyaluronan in fungi
08/31/2006WO2006089455A1 Targeting anti-tumour fusion protein containing adenovirus e4orf4 protein
08/31/2006WO2006089422A1 Protein and its use in diagnosing alzheimer's disease
08/31/2006WO2006074914A3 Human rna helicase and therapeutic uses thereof
08/31/2006WO2006073892A3 Phi 15 dna polymerase
08/31/2006WO2006073431A3 Avipox recombinants expressing foot and mouth disease virus genes
08/31/2006WO2006072563A3 Hemopexin-like structure as polypeptide-scaffold
08/31/2006WO2006069110A3 Enzymatic production of glycolic acid
08/31/2006WO2006066595A3 Recombinant production of serum albumin
08/31/2006WO2006066594A3 Alpha-amylase variants
08/31/2006WO2006066247A3 Methods and compositions for extending telomere length and increasing cell lifespan
08/31/2006WO2006065975A3 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
08/31/2006WO2006059105A3 Non-cytotoxic protein conjugates
08/31/2006WO2006044492A3 Methods for generating rat embryo-derived cell lines and genetic modification of rat genome
08/31/2006WO2006040574A3 Lipocalin protein
08/31/2006WO2006040340A3 Method for production of a compound in a eukaryotic cell
08/31/2006WO2006038107A3 Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein
08/31/2006WO2006036787A3 Promoter molecules isolated from brassica napus for use in plants
08/31/2006WO2006032781A3 Peptide derivatives, compositions and uses in therapeutic treatment of herpesvirus infection
08/31/2006WO2006032724A3 Novel laccase enzymes and their uses
08/31/2006WO2006026322A3 Aspartic proteinase protein gene non-coding regulatory elements for use in plants
08/31/2006WO2006023956A3 Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria
08/31/2006WO2006021724A3 Adeno-associated viral vector for exon skipping in a gene encoding a dispensable-domain protein
08/31/2006WO2006017856A3 Methods for constructing antibiotic resistance free vaccines
08/31/2006WO2005084355A3 Insecticidal toxin complex fusion proteins
08/31/2006WO2005076732A3 Peptide-pna chimera targeting inducible nitric oxide synthase
08/31/2006WO2005056020A8 Nf-kb oligonucleotide decoy molecules
08/31/2006WO2005047307A3 Il-18 binding proteins
08/31/2006WO2005032455A3 Combinatorially selected phosphorodithioate aptamer targeting ap-1
08/31/2006WO2005027631A3 Proteins which confer biotic and abiotic stress resistance in plants
08/31/2006WO2005018554A3 Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
08/31/2006WO2005016281A3 Diagnosis and treatment of malignant neoplasms
08/31/2006US20060195949 Environmental stress-tolerant plants
08/31/2006US20060195948 nucleic acid molecules encoding Na+/H+ exchanger polypeptides for extrusion of monovalent cations (most preferably sodium ions) from the cytosol of cells to provide the cell with increased salt tolerance
08/31/2006US20060195946 For biosynthesis of human growth hormone; monoclonal antibodies with effector function; signal sequences
08/31/2006US20060195945 Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants
08/31/2006US20060195944 Such as increased biomass, tolerance to cold, drought, and low nitrogen; making transgenic plants
08/31/2006US20060195943 plant size, vegetative growth, organ number, plant architecture and/or biomass that are altered with respect to wild type plants; food product
08/31/2006US20060195942 Expressed sequence tags for use in targeting and isolation of genes for plant protection and improvement
08/31/2006US20060195940 Transgenic plants having a modified carbohydrate content
08/31/2006US20060195939 Delta-8 desaturase and its use in making polyunsaturated fatty acids
08/31/2006US20060195938 Polynucleotides encoding insect acetyl coenzyme-A carboxylase and uses thereof
08/31/2006US20060195937 Compositions and methods for genetic modification of plants
08/31/2006US20060195936 Methods and compositions for tobacco plants with reduced nicotine
08/31/2006US20060195935 Selection of host cells expressing protein at high levels
08/31/2006US20060195932 Nucleic acid molecules and other molecules associated with the carbon assimilation pathway
08/31/2006US20060195931 Soybean cultivar 4136015
08/31/2006US20060195930 Soybean cultivar 3133014